Literature DB >> 28472280

Diversification of IgG effector functions.

Stylianos Bournazos1, Jeffrey V Ravetch1.   

Abstract

IgG is the major immunoglobulin class produced during an immune response against foreign antigens and efficiently provides protection through its bifunctional nature. While the Fab domains confer highly specific recognition of the antigen, the Fc domain mediates a wide range of effector functions that modulate several aspects of innate and adaptive immunity. Engagement of the various types of Fcγ receptors (FcγRs) by an IgG Fc domain can activate distinct immunomodulatory pathways with pleiotropic functional consequences for several leukocyte types. Fc effector functions are not limited to phagocytosis and cytotoxicity of IgG-opsonized targets but exhibit remarkable diversity and include modulation of leukocyte activity and survival, cytokine and chemokine expression, maturation of antigen-presenting cells, antigen processing and presentation, B-cell selection and IgG affinity maturation, as well as regulation of IgG production. These functions are initiated upon specific interactions of the Fc domain with the various types of FcγRs-a process that is largely determined by the structural heterogeneity of the IgG Fc domain. Modulation of the Fc-associated glycan structure and composition along with differences in the primary amino acid sequence among the IgG subclasses represent the two main diversification mechanisms of the Fc domain that generate a spectrum of Fc domain phenotypes with distinct affinity for the various FcγR types and differential capacity to activate immunomodulatory pathways. © The Japanese Society for Immunology. 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Fc domain; Fc receptors; antibodies; immunomodulation

Mesh:

Substances:

Year:  2017        PMID: 28472280      PMCID: PMC5890892          DOI: 10.1093/intimm/dxx025

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  96 in total

1.  Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

Authors:  P Sondermann; J Kaiser; U Jacob
Journal:  J Mol Biol       Date:  2001-06-08       Impact factor: 5.469

2.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

3.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

4.  Identification of a receptor required for the anti-inflammatory activity of IVIG.

Authors:  Robert M Anthony; Fredrik Wermeling; Mikael C I Karlsson; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

5.  Fc receptors are required in passive and active immunity to melanoma.

Authors:  R Clynes; Y Takechi; Y Moroi; A Houghton; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 6.  The coordination of signaling during Fc receptor-mediated phagocytosis.

Authors:  Joel A Swanson; Adam D Hoppe
Journal:  J Leukoc Biol       Date:  2004-10-05       Impact factor: 4.962

7.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

8.  General mechanism for modulating immunoglobulin effector function.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-22       Impact factor: 11.205

9.  Glycosylation of plasma IgG in colorectal cancer prognosis.

Authors:  Evropi Theodoratou; Kujtim Thaçi; Felix Agakov; Maria N Timofeeva; Jerko Štambuk; Maja Pučić-Baković; Frano Vučković; Peter Orchard; Anna Agakova; Farhat V N Din; Ewan Brown; Pauline M Rudd; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Gordan Lauc
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

10.  Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis.

Authors:  T Yuasa; S Kubo; T Yoshino; A Ujike; K Matsumura; M Ono; J V Ravetch; T Takai
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  38 in total

1.  Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways.

Authors:  Polina Weitzenfeld; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

2.  Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity.

Authors:  H A Daniel Lagassé; Hartmut Hengel; Basil Golding; Zuben E Sauna
Journal:  AAPS J       Date:  2019-05-06       Impact factor: 4.009

Review 3.  Non-canonical B cell functions in transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Hum Immunol       Date:  2019-04-10       Impact factor: 2.850

4.  Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.

Authors:  Inbal Farkash; Tali Feferman; Noy Cohen-Saban; Yahel Avraham; David Morgenstern; Grace Mayuni; Natasha Barth; Yaniv Lustig; Liron Miller; Dror S Shouval; Asaf Biber; Ilya Kirgner; Yishai Levin; Rony Dahan
Journal:  Cell Rep       Date:  2021-11-24       Impact factor: 9.423

Review 5.  Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.

Authors:  Dhuha H Nawab
Journal:  Hum Vaccin Immunother       Date:  2021-11-29       Impact factor: 3.452

6.  Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases.

Authors:  Yanxia Bi; Jian Su; Shengru Zhou; Yingjie Zhao; Yan Zhang; Huihui Zhang; Mingdong Liu; Aiwu Zhou; Jianrong Xu; Meng Pan; Yiming Zhao; Fubin Li
Journal:  Elife       Date:  2022-08-03       Impact factor: 8.713

7.  Glycosylation and Aging.

Authors:  Ana Cindrić; Jasminka Krištić; Marina Martinić Kavur; Marija Pezer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 8.  B Cell Responses: Cell Interaction Dynamics and Decisions.

Authors:  Jason G Cyster; Christopher D C Allen
Journal:  Cell       Date:  2019-04-18       Impact factor: 41.582

Review 9.  Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.

Authors:  Evan Rossignol; Galit Alter; Boris Julg
Journal:  J Infect Dis       Date:  2021-02-15       Impact factor: 5.226

Review 10.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.